DBV Technologies
Empresa biofarmacéutica francesa de propiedad pública con sede en Bagneux, Francia
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood.
Nº Q5204430 ★★
Poco común · Organizaciones
DBV Technologies
Empresa biofarmacéutica francesa de propiedad pública con sede en Bagneux, Francia
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood.
En Wikipedia
Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
Texto: Wikipedia en inglés, CC BY-SA 4.0. ·
Cartas cercanas
-
Biogen
Empresa multinacional de biotecnología estadounidense
Nº Q864338 ★★
Sin ofertas
-
A
AbCellera
Company in Vancouver, Canada
Nº Q30271491 ★
Sin ofertas
-
B
Bioderma
Company in Lyon, France
Nº Q16951811 ★
Sin ofertas
-
D
Debiopharm
Biopharmaceutical group
Nº Q3020834 ★
Sin ofertas
-
Allergan
Irish tax-registered pharmaceutical company
Nº Q906187 ★
Sin ofertas
-
S
Stallergenes Greer
Biopharmaceutical company
Nº Q3496440 ★
Sin ofertas